Biotech Sum of the Parts Valuation – Wall Street Prep

Ideal for investment banking private equity and VC professionals focusing on the biotechnology industry, you will learn how to build a biotech-sum-of-the-parts valuation the way it’s done on the job.

Real World “On the Job” Biotech SOTP Valuation

Want to value a clinical-stage, pre-revenue biotech? An ordinary discounted cash flow analysis won’t cut it. Instead, you need to build a long-range sum-of-the-parts valuation.

This 60-minute video short course + model template bridges the gap between academics and the real world and equips trainees with the practical modeling skill set needed to build a biotech SOTP Valuation.

This course assumes no prior knowledge in biotech company valuation.

Excel Model Template Included: A biotech sum-of-the-parts (SOTP) model template is included with this course

What You Will Learn

• Market size and model potential revenue for a therapeutic asset in clinical development
• Road-map the path to commercialization for a biotech through the FDA approval process
• Apply the appropriate “probability of success”” to a clinical-stage pre-revenue biotech company
• Apply key assumptions and tie together a long-range forecast of multiple products with a DCF analysis

Who is This Program For?

This biotech sum-of-the-parts valuation course is designed for professionals and those pursuing a career in the following finance careers:

• Investment Banking
• Venture Capital
• Private Equity
• Anyone who wants to learn how professionals build a biotech-sum-of-the-parts valuation

Course Extras

Taught by Bankers
Our instructors are former investment bankers who give lessons real-world context by connecting it to their experience on the desk.

Used on the Street
This is the same comprehensive course our corporate clients use to prepare their analysts and associates.

Free Unlimited Access to the WSP Support Center
Receive answers to questions, free downloads, and more from our staff of experienced investment bankers.

Course TOC

Biotech Sum of the Parts Valuation
1. Biotech SOTP course welcome
2. Biotech SOTP introduction
3. Course Downloads
4. Overview of a sum of the parts valuation
5. Major building blocks for a biotech SOTP
6. Model assumptions dashboard
7. Biotech company lifecycle
8. Identify peak revenue opportunity
9. Therapeutic areas overview
10. Product launch timing and uptake curve
11. Patent life and loss of exclusivity
12. Road to commercialization
13. FDA clinical trials
14. Building a commercial infrastructure
15. Completing the SOTP
16. Probability of success
17. Build out one part of the SOTP (Product #1)
18. Finalizing the valuation model
19. Valuation sensitivities
20. Example: Blueprint Medicines Corp
21. Biotech SOTP Course Review